Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study

23Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Background: In addition to smoking, genetic predisposition is believed to play a major role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Genetic association studies of new candidate genes in COPD may lead to improved understanding of the pathogenesis of the disease.Methods: Two proposed casual single nucleotide polymorphisms (SNP) (rs1051740, rs2234922) in microsomal epoxide hydrolase (EPHX1) and three SNPs (rs1801282, rs1800571, rs3856806) in peroxisome proliferator-activated receptor gamma (PPARG), a new candidate gene, were genotyped in a case-control study (272 COPD patients and 301 controls subjects) in Hungary. Allele frequencies and genotype distributions were compared between the two cohorts and trend test was also used to evaluate association between SNPs and COPD. To estimate the strength of association, odds ratios (OR) (with 95% CI) were calculated and potential confounding variables were tested in logistic regression analysis. Association between haplotypes and COPD outcome was also assessed.Results: The distribution of imputed EPHX1 phenotypes was significantly different between the COPD and the control group (P = 0.041), OR for the slow activity phenotype was 1.639 (95% CI = 1.08- 2.49; P = 0.021) in our study. In logistic regression analysis adjusted for both variants, also age and pack-year, the rare allele of His447His of PPARG showed significant association with COPD outcome (OR = 1.853, 95% CI = 1.09-3.14, P = 0.0218). In haplotype analysis the GC haplotype of PPARG (OR = 0.512, 95% CI = 0.27-0.96, P = 0.035) conferred reduced risk for COPD.Conclusions: The "slow" activity-associated genotypes of EPHX1 were associated with increased risk of COPD. The minor His447His allele of PPARG significantly increased; and the haplotype containing the minor Pro12Ala and the major His447His polymorphisms of PPARG decreased the risk of COPD. © 2010 Penyige et al; licensee BioMed Central Ltd.

References Powered by Scopus

SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

2076Citations
N/AReaders
Get full text

The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

1616Citations
N/AReaders
Get full text

A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1241Citations
N/AReaders
Get full text

Cited by Powered by Scopus

PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation

737Citations
N/AReaders
Get full text

Agonistic induction of PPARγ reverses cigarette smoke-induced emphysema

67Citations
N/AReaders
Get full text

Biology and therapeutic applications of peroxisome proliferator-activated receptors

58Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Penyige, A., Poliska, S., Csanky, E., Scholtz, B., Dezso, B., Schmelczer, I., … Nagy, L. (2010). Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. BMC Medical Genetics, 11(1). https://doi.org/10.1186/1471-2350-11-152

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

55%

Researcher 5

25%

Professor / Associate Prof. 3

15%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

50%

Biochemistry, Genetics and Molecular Bi... 4

20%

Nursing and Health Professions 3

15%

Agricultural and Biological Sciences 3

15%

Save time finding and organizing research with Mendeley

Sign up for free